127 related articles for article (PubMed ID: 32329050)
1. Prevalence and risk of thyroid diseases in myasthenia gravis.
Chou CC; Huang MH; Lan WC; Kong SS; Kuo CF; Chou IJ
Acta Neurol Scand; 2020 Sep; 142(3):239-247. PubMed ID: 32329050
[TBL] [Abstract][Full Text] [Related]
2. Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study.
Yeh JH; Kuo HT; Chen HJ; Chen YK; Chiu HC; Kao CH
Medicine (Baltimore); 2015 May; 94(21):e835. PubMed ID: 26020387
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course.
Kubiszewska J; Szyluk B; Szczudlik P; Bartoszewicz Z; Dutkiewicz M; Bielecki M; Bednarczuk T; Kostera-Pruszczyk A
Brain Behav; 2016 Oct; 6(10):e00537. PubMed ID: 27781146
[TBL] [Abstract][Full Text] [Related]
5. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
[TBL] [Abstract][Full Text] [Related]
6. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
Lai CH; Tseng HF
Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
[TBL] [Abstract][Full Text] [Related]
7. Thyroid disorders in patients with myasthenia gravis: A systematic review and meta-analysis.
Song RH; Yao QM; Wang B; Li Q; Jia X; Zhang JA
Autoimmun Rev; 2019 Oct; 18(10):102368. PubMed ID: 31404702
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan.
Chen YL; Yeh JH; Chiu HC
Acta Neurol Scand; 2013 Mar; 127(3):170-4. PubMed ID: 22725712
[TBL] [Abstract][Full Text] [Related]
9. Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study.
Chang CC; Lin TM; Chang YS; Chen WS; Sheu JJ; Chen YH; Chen JH
Rheumatology (Oxford); 2019 Jan; 58(1):135-143. PubMed ID: 30189048
[TBL] [Abstract][Full Text] [Related]
10. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
12. The Epidemiology of Myasthenia Gravis in Korea.
Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.
Chang YK; Tseng YT; Chen KH; Chen KT
BMC Endocr Disord; 2019 Apr; 19(1):36. PubMed ID: 30953492
[TBL] [Abstract][Full Text] [Related]
14. Fracture rate in patients with myasthenia gravis: the general practice research database.
Pouwels S; de Boer A; Javaid MK; Hilton-Jones D; Verschuuren J; Cooper C; Leufkens HG; de Vries F
Osteoporos Int; 2013 Feb; 24(2):467-76. PubMed ID: 22531999
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis in myasthenia gravis.
Ou SM; Liu CJ; Chang YS; Hu YW; Chao PW; Chen TJ; Tzeng CH; Wang SJ
Int J Tuberc Lung Dis; 2013 Jan; 17(1):79-84. PubMed ID: 23232007
[TBL] [Abstract][Full Text] [Related]
16. Risk of diabetes mellitus among patients with myasthenia gravis.
Yeh JH; Chen HJ; Lin CC; Chen YK; Chiu HC; Kao CH
Acta Neurol Scand; 2015 Aug; 132(2):132-8. PubMed ID: 25630759
[TBL] [Abstract][Full Text] [Related]
17. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
[TBL] [Abstract][Full Text] [Related]
18. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
19. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
[TBL] [Abstract][Full Text] [Related]
20. The association between scabies and myasthenia gravis: A nationwide population-based cohort study.
Hsu RJ; Lin CY; Chang FW; Huang CF; Chuang HC; Liu JM
J Clin Neurosci; 2017 Nov; 45():115-120. PubMed ID: 28890037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
